Search results
Harry and Meghan branded ‘frauds' over Archie and Lilibet decision
Daily Express· 12 hours agoPrince Harry and Meghan Markle were slammed by a royal commentator who called them out on their...
‘What they left behind’: Ernie Pyle recalls the carnage of Omaha Beach
Military Times via Yahoo News· 56 minutes agoBut can we truly appreciate the human cost of that victory — the horrors that Allied troops had to...
Eleven tonnes of rubbish taken off Himalayan peaks
BBC via Yahoo News· 8 minutes agoThe preliminary order didn't set a maximum number. Mr Gurung says he welcomes the order and the government is thinking about reforms such as staggering...
San Antonio's Zachry axes 4,410 workers after Golden Pass woes
San Antonio Express-News· 2 hours agoThe company said in a statement it was “forced to take decisive action to protect our business”...
Misinformation About Mexico’s Historic Election Is Spreading. Here’s What to Know.
Teen Vogue via Yahoo News· 4 hours agoActivists noted excessive use of force against women during demonstrations during her mayorship. In...
'It pays to be Clarence': Data shows justice raked in 'staggering' $4 million in gifts
The Raw Story· 1 hour agoOutrage erupted Thursday as word spread of the new "staggering tally" of Supreme Court gifts which...
55 Inspiring Quotes To Remember the Battle of Normandy on the 80th Anniversary of D-Day
Parade via AOL· 6 hours agoAlthough D-Day was a successful mission, it is believed that a staggering 10,500 Allied forces were...
The US just carried out back-to-back ICBM launches, keeping the Minuteman III sharp until a new...
Business Insider via Yahoo News· 3 hours agoSome estimations suggest the program is now likely to cost over $131 billion. The increase is so ...
The biggest box-office disappointments of 2024 so far
INSIDER via Yahoo News· 3 hours agoStrikes, streaming, and lackluster films contributed to the worst Memorial Day box office since the...
Is Viking Therapeutics Stock a Buy on the Dip?
The Motley Fool via AOL· 7 hours agoViking Therapeutics (NASDAQ: VKTX) is an anomaly of sorts. Despite another underwhelming year for biotech stocks, the metabolic disease specialist has,...
